ReviewJournal of cardiovascular development and disease2023

Targeted Atrial Fibrillation Therapy and Risk Stratification Using Atrial Alternans.

Neha Muthavarapu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.